Suggested Topics within your search.
Suggested Topics within your search.
-
21201
Efficacy and safety of TQB2450 combined with anlotinib as maintenance therapy for LS-SCLC after definitive concurrent or sequential chemoradiotherapy: a prospective phase Ib study
Published 2025-03-01“…This prospective study aimed to evaluate the efficacy and safety of TQB2450 combined with Anlotinib as maintenance therapy for LS-SCLC following concurrent or sequential chemoradiotherapy (CCRT or SCRT). …”
Get full text
Article -
21202
Impact of TNF inhibitors on inflammation-associated cognitive dysfunction in patients with rheumatoid arthritis: a prospective analysis
Published 2025-04-01“…ObjectivesTo evaluate cognitive improvement in patients with rheumatoid arthritis (RA) after 6 months of treatment with tumor necrosis factor (TNF) inhibitors, analyze associated factors, and determine the percentage of patients achieving cognitive improvement.MethodsThis was a single-center prospective observational study conducted over 12 months on 70 RA patients initiating their first biologic disease-modifying antirheumatic drug (bDMARD) with a TNF inhibitor. …”
Get full text
Article -
21203
Synthesis of Iron-Based and Aluminum-Based Bimetals: A Systematic Review
Published 2025-05-01“…Additionally, a bibliometric analysis was performed to evaluate the research trends on the synthesis of Fe-based and Al-based bimetals. …”
Get full text
Article -
21204
Targeting N4‐acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2‐mediated HMGB2 mRNA translation
Published 2024-09-01“…Methods The ac4C levels were evaluated by dot blot and ultra‐performance liquid chromatography‐tandem mass spectrometry with harvested HCC tissues. …”
Get full text
Article -
21205
Adverse fetal and perinatal outcomes associated with Zika virus infection during pregnancy: an individual participant data meta-analysisResearch in context
Published 2025-05-01“…Frequentist and Bayesian regression methods were applied to estimate outcome prevalence and evaluate the association between maternal ZIKV infection and fetal loss, microcephaly and congenital zika syndrome as primary outcomes. …”
Get full text
Article -
21206
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer
Published 2024-10-01“…The suboptimal efficacy of neoadjuvant chemotherapy-sparing, ICI-based regimens in this patient subset underscores the importance of tumor molecular testing prior to initiation of neoadjuvant ICI therapy in patients with resectable NSCLC.…”
Get full text
Article -
21207
PSMB10 maintains the stemness of chemotherapeutic drug-resistant leukemia cells by inhibiting senescence and cytotoxic T lymphocyte-mediated killing in a ubiquitinated degradation...
Published 2025-06-01“…The cellular senescence was evaluated by the assays of cell proliferation, cell cycle, senescence-associated β-galactosidase activity, and senescence-associated secretory phenotype factors. …”
Get full text
Article -
21208
Home Blood Pressure Control and Drug Prescription Patterns among Thai Hypertensives: A 1-Year Analysis of Telehealth Assisted Instrument in Home Blood Pressure Monitoring Nationwid...
Published 2021-01-01“…However, the enhancement of blood pressure (BP) control with HBP telemonitoring technology has yet to be studied in Thailand. Objective. To evaluate the attainment of HBP control and drug prescription patterns in Thai hypertensives at one year after initiating the TeleHealth Assisted Instrument in Home Blood Pressure Monitoring (THAI HBPM) nationwide pilot project. …”
Get full text
Article -
21209
Human PrP E219K: a new and promising substrate for robust RT-QuIC amplification of human prions with potential for strain discrimination
Published 2025-08-01“…In tg650-passaged prions, amplification reactions were initiated between 3 and 36 hours for sCJD prions and between 11 and 31 hours for vCJD prions, covering a 5- to 7-log dilution range depending on the strain. …”
Get full text
Article -
21210
Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury
Published 2025-05-01“…Blood-based biomarkers for inflammation and neuronal and glial injury have been evaluated as potential markers of disease severity and prognosis in AE.MethodsPatients diagnosed with LGI1 AE, confirmed by cell-based assay, were enrolled and followed prospectively to gather plasma samples for biomarker testing. …”
Get full text
Article -
21211
Global perspectives on challenges, coping strategies, and future preparedness of nursing home staff during COVID-19: a systematic review and meta-synthesis
Published 2025-07-01“…Two reviewers used the Joanna Briggs Institute's (JBI) qualitative research checklist to evaluate each manuscript. The findings were synthesized using pragmatic meta-aggregators. …”
Get full text
Article -
21212
NeoTRACK trial: Neoadjuvant TiRagolumab, Atezolizumab and Chemotherapy – dissection of IO- efficacy in NSCLC by longitudinal tracKing – protocol of a non-randomised, open-label, si...
Published 2025-03-01“…Several trials are currently investigating the combination of neoadjuvant platinum-based chemotherapy and dual checkpoint inhibition prior to curative surgery. The investigator-initiated NeoTRACK trial (EU CT number: 2022-501322-38-00; ClinicalTrials.gov identifier: NCT05825625; IKF056) aims to evaluate the feasibility and safety of perioperative anti-PD-L1 (by atezolizumab) and anti-TIGIT (by tiragolumab) treatment in combination with chemotherapy in patients with early stage NSCLC.Methods and analysis NeoTRACK is an open-label, single-arm, prospective, bicentric phase II trial. …”
Get full text
Article -
21213
Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV–GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors
Published 2024-11-01“…The dose-expansion phase was not initiated. The primary objectives were to evaluate safety and tolerability, dose-limiting toxicities (DLTs) and the dose and schedule of MEDI5395 plus durvalumab administration. …”
Get full text
Article -
21214
Ibrutinib in the Treatment of Refractory Chronic Lymphocytic Leukemia
Published 2017-07-01“…Atrial fibrillation was registered in 5 patients, who initially had sinus rhythm. The total of 144 infections were diagnosed in 64 (66 %) patients. …”
Get full text
Article -
21215
Long-term results of a randomized controlled trial of biosimilar CT-P16 and reference bevacizumab in patients with metastatic or recurrent non-small cell lung cancer
Published 2025-01-01“…They were then followed up every 9 weeks until death or end of study. Outcomes were evaluated ≤3 years after the last patient enrollment. …”
Get full text
Article -
21216
HELLO: a protocol for a cluster randomized controlled trial to enhance interpersonal relationships and team cohesion among ICU healthcare professionals
Published 2024-10-01“…The six components include: Hello campaign posters, email reminders, integrating greetings in morning huddles, hello jars, lead-by-example initiatives, and a daily updated hello board in each ICU. …”
Get full text
Article -
21217
Stillbirth increase long-term health risks of diabetes, CVD, CVD mortality, and all-cause mortality
Published 2025-07-01“…Multivariate Cox regressions were used to evaluate associations of stillbirths with diabetes, CVD, all-cause mortality, and CVD mortality utilizing hazard ratios (HRs) and 95% confidence intervals (CIs). …”
Get full text
Article -
21218
Stability of non-fullerene acceptor-based organic solar cells: chemical and physical properties at the interfaces and active layer
Published 2024-01-01“…The TOF-SIMS and XPS analyses confirmed that oxygen did not diffuse into the layers where it was initially absent, thereby ensuring chemical stability. …”
Get full text
Article -
21219
The brainstem BBSome regulates glucose homeostasis and lean mass in a state-dependent manner
Published 2025-10-01Get full text
Article -
21220